retatrutide trials Seeking Differentiation Through a Triple Mechanism" Eli Lilly's Again Proves Efficacy in Trials, Raising Question of Whether It Can Overcome Side-Effect Limits and Reshape the Market Retatrutide Phase 3: TRIUMPH Program

Table of Contents What Are GLP-1 Receptor Agonists and How Do They Work

In Phase 2 obesity trials, retatrutide produced approximately 24% mean body-weight reduction at 48 weeks at the 12 mg dose the largest weight-loss effect reported for any GLP-1-class compound to date

Take your symptoms seriously

This is especially important for people with diabetes who also have heart issues, kidney problems, or are overweight

J Clin Endocrinol Metab 93(9):33733380

Christopher McGowan, MD, a gastroenterologist and obesity medicine specialist, told Medical News Today that: Losing weight at the expense of lean muscle can lead to future problems, including reduced basal metabolic rate, decreased strength, fitness, and tone, reduced bone density, and an increased risk of weight recurrence